The fact that we found an increase in AnxA1 serum levels brings an alternative approach to help in the diagnosis of melanoma, and a large cohort is needed to support the potential of AnxA1 as a biomarker for melanoma detection or progression. The gene discussed is ANXA1; the disease is melanoma.